Caribou Biosciences Inc (CRBU)

$1.99 +0.01 (0.25%)
Market Cap 184.85M
Revenue (ttm) 9.99M
Net Income (ttm) -149.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,492.59%
Debt to Equity Ratio 0.00
Volume 1,378,100
Avg Vol 2,649,548
Day's Range N/A - N/A
Shares Out 93.12M
Stochastic %K 13%
Beta 2.59
Analysts Strong Sell
Price Target $9.75

Company Profile

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 982 6030
Address:
2929 7th Street, Suite 105, Berkeley, United States
josegodoy
josegodoy Nov. 14 at 9:11 PM
$CRBU PFE has its window, True…but don’t sleep “Novo Nordisk attempted to swoop in and snatch the startup from under Pfizer’s nose” https://www.fiercebiotech.com/biotech/pfizer-finalizes-metsera-buy-after-contentious-bidding-war-novo-nordisk
0 · Reply
RocroBio
RocroBio Nov. 13 at 10:18 PM
$CRBU
0 · Reply
ebodonicus
ebodonicus Nov. 13 at 8:45 PM
$CRBU today strikes me as a time to buy. Everything’s red.
0 · Reply
haydenjc
haydenjc Nov. 13 at 6:16 PM
$CRBU well damn, buying more tomorrow!!!
0 · Reply
3DBuilds
3DBuilds Nov. 13 at 6:13 PM
$CRBU $NTLA $PRME $CRSP $VERV This is wild on why these stocks are down right now 💯 what a Great time to be Buying 💰 🌎
0 · Reply
3DBuilds
3DBuilds Nov. 13 at 5:59 PM
$CRBU what an Amazing time to Buy right now 💯 💰 🌎
0 · Reply
haydenjc
haydenjc Nov. 13 at 5:41 PM
$CRBU shit, I will take more at 2.04!!!!
0 · Reply
Peterson28
Peterson28 Nov. 13 at 3:08 PM
$CRBU The market is upset that they didn’t tap into the ATM hence a low cash level which is not enough to complete the phase 3.
1 · Reply
ChicagoJoe20
ChicagoJoe20 Nov. 13 at 12:34 PM
$CRBU gents, $IMMX and $ALLO. I won't suggest any in vivo companies yet. ;)
0 · Reply
NicaInvest85
NicaInvest85 Nov. 13 at 2:19 AM
$CRBU as expected the company is heading to the $6-$9 range as the equity analyst consensus is expecting. The data is looking awesome and the breakthrough will be the turning point for this gene editing and Caribou
2 · Reply
Latest News on CRBU
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 12, 2025, 4:05 PM EST - 2 days ago

Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Caribou Biosciences to Participate in Upcoming Investor Conferences

Nov 3, 2025, 5:15 PM EST - 11 days ago

Caribou Biosciences to Participate in Upcoming Investor Conferences

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

Nov 3, 2025, 11:48 AM EST - 11 days ago

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

Nov 3, 2025, 7:00 AM EST - 11 days ago

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

Nov 3, 2025, 7:00 AM EST - 11 days ago

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

Nov 2, 2025, 4:00 PM EST - 12 days ago

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

Aug 25, 2025, 4:05 PM EDT - 2 months ago

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 12, 2025, 4:05 PM EDT - 3 months ago

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

May 28, 2025, 4:00 PM EDT - 6 months ago

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

May 8, 2025, 4:05 PM EDT - 6 months ago

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

May 6, 2025, 4:00 PM EDT - 6 months ago

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Apr 24, 2025, 4:15 PM EDT - 7 months ago

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect

Apr 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out

Apr 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation

Apr 6, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 3, 2025, 10:00 AM EDT - 8 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 1, 2025, 10:00 AM EDT - 8 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect

Mar 30, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation

Mar 27, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation

Mar 25, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out

Mar 20, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect

Mar 18, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 16, 2025, 10:00 AM EDT - 8 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Stockholders to Learn More About the Investigation

Mar 13, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Investors to Inquire about Securities Investigation

Mar 11, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Investors to Inquire about Securities Investigation

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 10, 2025, 4:05 PM EDT - 8 months ago

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

Feb 24, 2025, 5:45 AM EST - 9 months ago

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 23, 2025, 9:27 AM EST - 9 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU

Feb 20, 2025, 1:28 PM EST - 9 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 19, 2025, 10:22 AM EST - 9 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights

Feb 15, 2025, 3:04 PM EST - 9 months ago

CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Jan 29, 2025, 10:51 AM EST - 10 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

josegodoy
josegodoy Nov. 14 at 9:11 PM
$CRBU PFE has its window, True…but don’t sleep “Novo Nordisk attempted to swoop in and snatch the startup from under Pfizer’s nose” https://www.fiercebiotech.com/biotech/pfizer-finalizes-metsera-buy-after-contentious-bidding-war-novo-nordisk
0 · Reply
RocroBio
RocroBio Nov. 13 at 10:18 PM
$CRBU
0 · Reply
ebodonicus
ebodonicus Nov. 13 at 8:45 PM
$CRBU today strikes me as a time to buy. Everything’s red.
0 · Reply
haydenjc
haydenjc Nov. 13 at 6:16 PM
$CRBU well damn, buying more tomorrow!!!
0 · Reply
3DBuilds
3DBuilds Nov. 13 at 6:13 PM
$CRBU $NTLA $PRME $CRSP $VERV This is wild on why these stocks are down right now 💯 what a Great time to be Buying 💰 🌎
0 · Reply
3DBuilds
3DBuilds Nov. 13 at 5:59 PM
$CRBU what an Amazing time to Buy right now 💯 💰 🌎
0 · Reply
haydenjc
haydenjc Nov. 13 at 5:41 PM
$CRBU shit, I will take more at 2.04!!!!
0 · Reply
Peterson28
Peterson28 Nov. 13 at 3:08 PM
$CRBU The market is upset that they didn’t tap into the ATM hence a low cash level which is not enough to complete the phase 3.
1 · Reply
ChicagoJoe20
ChicagoJoe20 Nov. 13 at 12:34 PM
$CRBU gents, $IMMX and $ALLO. I won't suggest any in vivo companies yet. ;)
0 · Reply
NicaInvest85
NicaInvest85 Nov. 13 at 2:19 AM
$CRBU as expected the company is heading to the $6-$9 range as the equity analyst consensus is expecting. The data is looking awesome and the breakthrough will be the turning point for this gene editing and Caribou
2 · Reply
Bayesed
Bayesed Nov. 12 at 9:31 PM
$CRBU NOT stripped for cash like some were claiming From Reuters: "Company maintains $159.2 mln in cash for funding operations into 2H 2027 Caribou expects to fund operations into 2H 2027 with current resources".
0 · Reply
Bayesed
Bayesed Nov. 12 at 9:21 PM
$CRBU Q3 2025 Licensing and collaboration review of 2.198m higher than that of Q3 2024. Net income highest since Q4 2023 Basic EPS of -0.3 beat expectations of -0.36
1 · Reply
Peterson28
Peterson28 Nov. 12 at 9:16 PM
$CRBU Q3 out. Not much new updates. Didn't tape into the ATM. So what they have been waiting for if not BO.
1 · Reply
Bayesed
Bayesed Nov. 12 at 9:03 PM
$CRBU Price hovering near lowest low VWAP: AA. Twice as low as highest high and highest volume VWAP: AAs. It is being pushed down but current price is much lower than its true trading value. won't stay here for long and the only way is up. Let's see what the earnings report does.
0 · Reply
Peterson28
Peterson28 Nov. 12 at 4:36 PM
$CRBU So it is like being intentionally capped at sub-2 levels. I bet the BO offer is something around $4-5 plus $4-5 CVR.
2 · Reply
GenomicEquities
GenomicEquities Nov. 12 at 3:58 PM
$CRBU I wanna take the “no news” as bullish. If it was a simple ordinary earnings call it would have happened. Right?
1 · Reply
Sumner36
Sumner36 Nov. 12 at 12:44 PM
$CRBU Does anyone have a definitive date for the 3Q earnings release? I have found 7 different dates when researching.
4 · Reply
Mogeyman
Mogeyman Nov. 12 at 10:42 AM
$CRBU
0 · Reply
NicaInvest85
NicaInvest85 Nov. 11 at 10:41 PM
$CRBU Warren Buffet said don’t buy the stock buy the business and Caribou Bioscience has at least the intellectual property and hopefully the breakthrough. Longterm investment - they are getting close. The data is looking good.
0 · Reply
Ed202020
Ed202020 Nov. 11 at 8:54 PM
$CRBU to the moon - go
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 11 at 8:54 PM
$CRBU back the boo
0 · Reply
NicaInvest85
NicaInvest85 Nov. 11 at 7:25 PM
$CRBU did Rachel bought some shares worth $20K?
0 · Reply